ARS Pharmaceuticals' Neffy Launch Could Be A Hit For Severe Allergic Reactions
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.
News Medical2d
New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
Green Matters on MSN2d
Viral Video Reveals the Right Way to Use Flonase, Because Apparently We're All Doing It Wrong
A doctor explains how to correctly use Flonase nasal spray, which includes manually opening your sinuses before you spray.
Medscape2d
Warning of Confusion Between Nasal and IV Epinephrine
Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to ...
EurekAlert!3d
Nasal COVID-19 vaccine based on WashU technology to enter US clinical trials
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
Inquirer on MSN4d
World’s first anti-depression nasal spray receives FDA approval
The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more potent ...
News on 64d
FDA expands approval for antidepressant nasal spray
The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...
healthday16d
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...
The Hill16d
Nose spray to treat depression? FDA approves first-of-its-kind medicine
The nasal spray can be given to people who haven’t seen improvements in their depression after taking at least two oral medications, according to Johnson & Johnson. The main ingredient for the ...
Newsweek16d
FDA Approves Nasal Spray for Depression
The U.S. Food and Drug Administration (FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with treatment ...
CNN17d
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...